Related references
Note: Only part of the references are listed.Indoleamine 2,3-dioxygenase as a Modifier of Pathogenic Inflammation in Cancer and other Inflammation-Associated Diseases
G. C. Prendergast et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood
Ana Pocivavsek et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2012)
Regulation of quinolinic acid neosynthesis in mouse, rat and human brain by iron and iron chelators in vitro
Erin K. Stachowski et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery
Flavio Moroni et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Interleukin-1β: A New Regulator of the Kynurenine Pathway Affecting Human Hippocampal Neurogenesis
Patricia A. Zunszain et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Interaction and transport of kynurenic acid via human organic anion transporters hOAT1 and hOAT3
Yuichi Uwai et al.
PHARMACOLOGICAL RESEARCH (2012)
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
Luc Pilotte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
Klas R. Linderholm et al.
SCHIZOPHRENIA BULLETIN (2012)
Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
F. Fazio et al.
MOLECULAR PHARMACOLOGY (2012)
Downregulated Kynurenine 3-Monooxygenase Gene Expression and Enzyme Activity in Schizophrenia and Genetic Association With Schizophrenia Endophenotypes
Ikwunga Wonodi et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
α-methyl-L-tryptophan: mechanisms for tracer localization of epileptogenic brain regions
Diane C. Chugani
BIOMARKERS IN MEDICINE (2011)
Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
Daniel Zwilling et al.
CELL (2011)
The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease
Susanna Campesan et al.
CURRENT BIOLOGY (2011)
Effect of some naturally occurring iron ion chelators on the formation of radicals in the reaction mixtures of rat liver microsomes with ADP, Fe3+ and NADPH
Katsuyuki Minakata et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2011)
Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders
Gregory F. Oxenkrug
JOURNAL OF NEURAL TRANSMISSION (2011)
Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?
Johann Steiner et al.
JOURNAL OF NEUROINFLAMMATION (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
Cognitive dysfunction in depression: Neurocircuitry and new therapeutic strategies
James W. Murrough et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2011)
Fluctuations in Endogenous Kynurenic Acid Control Hippocampal Glutamate and Memory
Ana Pocivavsek et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Depression, Antidepressants, and Neurogenesis: A Critical Reappraisal
Nicola D. Hanson et al.
NEUROPSYCHOPHARMACOLOGY (2011)
On the antioxidant properties of kynurenic acid: Free radical scavenging activity and inhibition of oxidative stress
R. Lugo-Huitron et al.
NEUROTOXICOLOGY AND TERATOLOGY (2011)
Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine
Kathleen S. Alexander et al.
PSYCHOPHARMACOLOGY (2011)
Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia
Korrapati V. Sathyasaikumar et al.
SCHIZOPHRENIA BULLETIN (2011)
Administration of kynurenine during adolescence, but not during adulthood, impairs social behavior in rats
Katelyn V. Trecartin et al.
SCHIZOPHRENIA RESEARCH (2011)
Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression
Anthony Laugeray et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Functional and Dysfunctional Synaptic Plasticity in Prefrontal Cortex: Roles in Psychiatric Disorders
Yukiori Goto et al.
BIOLOGICAL PSYCHIATRY (2010)
Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions
Ross J. Tynan et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
Structure, expression, and function of kynurenine aminotransferases in human and rodent brains
Qian Han et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Dendritic Cells, Indoleamine 2,3 Dioxygenase and Acquired Immune Privilege
Lei Huang et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2010)
The Astrocyte-Derived alpha 7 Nicotinic Receptor Antagonist Kynurenic Acid Controls Extracellular Glutamate Levels in the Prefrontal Cortex
Hui-Qiu Wu et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2010)
Inhibition of the Kynurenine-NAD+ Pathway Leads to Energy Failure and Exacerbates Apoptosis in Pneumococcal Meningitis
Caroline L. Bellac et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
Elevated levels of kynurenic acid in the cerebrospinal fluid of patients with bipolar disorder
Sara K. Olsson et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2010)
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression
C. L. Raison et al.
MOLECULAR PSYCHIATRY (2010)
Kynurenine is an endothelium-derived relaxing factor produced during inflammation
Yutang Wang et al.
NATURE MEDICINE (2010)
Microglia in neurodegenerative disease
V. Hugh Perry et al.
NATURE REVIEWS NEUROLOGY (2010)
Indoleamine 2,3-dioxygenase and 3-hydroxy-kynurenine modifications are found in the neuropathology of Alzheimer's disease
David J. Bonda et al.
REDOX REPORT (2010)
Kynurenic Acid Is a Potent Endogenous Aryl Hydrocarbon Receptor Ligand that Synergistically Induces Interleukin-6 in the Presence of Inflammatory Signaling
Brett C. DiNatale et al.
TOXICOLOGICAL SCIENCES (2010)
L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning
Amy C. Chess et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis
Jean Rodgers et al.
BRAIN (2009)
Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release
A. Zmarowski et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Effect of indoleamine dioxygenase-1 deficiency and kynurenine pathway inhibition on murine cerebral malaria
Jenny Miu et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2009)
Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway
Helen J. Ball et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Induction of IDO by Bacille Calmette-Guerin Is Responsible for Development of Murine Depressive-Like Behavior
Jason C. O'Connor et al.
JOURNAL OF IMMUNOLOGY (2009)
On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo
Laura Amori et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Interferon-γ and Tumor Necrosis Factor-α Mediate the Upregulation of Indoleamine 2,3-Dioxygenase and the Induction of Depressive-Like Behavior in Mice in Response to Bacillus Calmette-Guerin
Jason C. O'Connor et al.
JOURNAL OF NEUROSCIENCE (2009)
Electrophysiological characterisation of the actions of kynurenic acid at ligand-gated ion channels
M. H. Selina Mok et al.
NEUROPHARMACOLOGY (2009)
SPECIFIC INHIBITION OF KYNURENATE SYNTHESIS ENHANCES EXTRACELLULAR DOPAMINE LEVELS IN THE RODENT STRIATUM
L. Amori et al.
NEUROSCIENCE (2009)
Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function
Edson X. Albuquerque et al.
PHYSIOLOGICAL REVIEWS (2009)
The Excitotoxin Quinolinic Acid Induces Tau Phosphorylation in Human Neurons
Abdur Rahman et al.
PLOS ONE (2009)
Glutamate-based antidepressants: 20 years on
Phil Skolnick et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice
Masaaki Kanai et al.
MOLECULAR BRAIN (2009)
Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys
Laurent Gregoire et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review
Stephane Potvin et al.
BIOLOGICAL PSYCHIATRY (2008)
Glial activation precedes seizures and hippocampal neurodegeneration in measles virus-infected mice
Elin Lehrmann et al.
EPILEPSIA (2008)
Autism-like behavioral phenotypes in BTBR T+tf/J mice
H. G. McFarlane et al.
GENES BRAIN AND BEHAVIOR (2008)
Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance & neurotoxicity
Robert Owe-Young et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Xanthurenic acid distribution, transport, accumulation and release in the rat brain
Serge Gobaille et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge:: A role for IFN-γ?
Thomas J. Connor et al.
NEUROSCIENCE LETTERS (2008)
Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment
Flaviano Giorgini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: A pharmacological analysis
Klas R. Linderholm et al.
NEUROPHARMACOLOGY (2007)
Impaired dexamethasone-mediated induction of tryptophan 2,3-dioxygenase in heme-deficient rat hepatocytes:: Translational control by a hepatic elF2α kinase, the heme-regulated inhibitor
Mingxiang Liao et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Characterization of the kynurenine pathway in human neurons
Gilles J. Guillemin et al.
JOURNAL OF NEUROSCIENCE (2007)
Microglial activation in presymptomatic Huntington's disease gene carriers
Yen F. Tai et al.
BRAIN (2007)
Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at α7*nicotinic receptors
Cristiane Lopes et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain
Paolo Guidetti et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats
Trevor W. Stone
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Elevations of endogenous kynurenic acid produce spatial working memory deficits
Amy C. Chess et al.
SCHIZOPHRENIA BULLETIN (2007)
Perinatal kynurenine 3-hydroxylase inhibition in rodents: Pathophysiological implications
Gianpiera Ceresoli-Borroni et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Tissue expression and biochemical characterization of human 2-amino 3-carboxymuconate 6-semialdehyde decarboxylase, a key enzyme in tryptophan catabolism
Lisa Pucci et al.
FEBS JOURNAL (2007)
Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry
Paolo Guidetti et al.
GLIA (2007)
Modulation of the function of presynaptic α7 and non-α7 nicotinic receptors by the tryptophan metabolites, 5-hydroxyindole and kynurenate in mouse brain
M. Grilli et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain
G. Ceresoli-Borroni et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35
Jinghong Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant Fluoxetine treatment
Boldizsar Czeh et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO
Maria L. Belladonna et al.
JOURNAL OF IMMUNOLOGY (2006)
Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice
Paolo Guidetti et al.
NEUROBIOLOGY OF DISEASE (2006)
4-Chloro-3-hydroxyanthranilate reduces local quinolinic acid synthesis, improves functional recovery, and preserves white matter after spinal cord injury
Jennifer R. Yates et al.
JOURNAL OF NEUROTRAUMA (2006)
Association study between kynurenine 3-monooxygenase gene and schizophrenia in the Japanese population
N. Aoyama et al.
GENES BRAIN AND BEHAVIOR (2006)
Modulators of the kynurenine pathway of tryptophan metabolism:: Synthesis and preliminary biological evaluation of (S)-4-(ethylsulfonyl)benzoylaianine, a potent and selective kynurenine aminotransferase II (KAT II) inhibitor
Roberto Pellicciari et al.
CHEMMEDCHEM (2006)
Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease
MT Sapko et al.
EXPERIMENTAL NEUROLOGY (2006)
Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus
GJ Guillemin et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2005)
Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition
CJ Clark et al.
INFECTION AND IMMUNITY (2005)
Measurement of tryptophan, kynurenine and neopterin in women with and without postpartum blues
C Kohl et al.
JOURNAL OF AFFECTIVE DISORDERS (2005)
Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum
A Rassoulpour et al.
JOURNAL OF NEUROCHEMISTRY (2005)
A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease
F Giorgini et al.
NATURE GENETICS (2005)
Identification of kynurenine pathway enzyme mRNAs and metabolites in human placenta: Up-regulation by inflammatory stimuli and with clinical infection
U Manuelpillai et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia
CL Miller et al.
NEUROBIOLOGY OF DISEASE (2004)
Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific
B Baban et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2004)
Endogenous kynurenic acid disrupts prepulse inhibition
S Erhardt et al.
BIOLOGICAL PSYCHIATRY (2004)
Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient mice
P Yu et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease
P Guidetti et al.
NEUROBIOLOGY OF DISEASE (2004)
Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression
XH Si et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Elaborate interactions between the immune and nervous systems
L Steinman
NATURE IMMUNOLOGY (2004)
IDO expression by dendritic cells: Tolerance and tryptophan catabolism
AL Mellor et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Interferon-alpha-induced changes in tryptophan metabolism: Relationship to depression and paroxetine treatment
L Capuron et al.
BIOLOGICAL PSYCHIATRY (2003)
Micromolar brain levels of kynurenic acid are associated with a disruption of auditory sensory gating in the rat
PD Shepard et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Electrochemical and in vitro evaluation of the redox-properties of kynurenine species
GI Giles et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Manipulation of brain kynurenines: Glial targets, neuronal effects, and clinical opportunities
R Schwarcz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation
M Maes et al.
LIFE SCIENCES (2002)
Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis
K Sakurai et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid
S Erhardt et al.
ACTA PHYSIOLOGICA SCANDINAVICA (2002)
2-amino-4-[3′-hydroxyphenyl]-4-hydroxybutanoic acid;: A potent inhibitor of rat and recombinant human kynureninase
HA Walsh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
Immunohistochemical visualization of newly formed quinolinate in the normal and excitotoxically lesioned rat striatum
E Lehrmann et al.
EXPERIMENTAL BRAIN RESEARCH (2001)
Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia
S Erhardt et al.
NEUROSCIENCE LETTERS (2001)
Increased cortical kynurenate content in schizophrenia
R Schwarcz et al.
BIOLOGICAL PSYCHIATRY (2001)
Neonatal asphyxia in rats: Acute effects on cerebral kynurenine metabolism
G Ceresoli-Borroni et al.
PEDIATRIC RESEARCH (2001)
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
GJ Guillemin et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Similarities and differences in the neuronal death processes activated by 3OH-kynurenine and quinolinic acid
A Chiarugi et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Presynaptic kynurenate-sensitive receptors inhibit glutamate release
R Carpenedo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Quinolinic acid-iron(II) complexes: Slow autoxidation, but enhanced hydroxyl radical production in the Fenton reaction
J Platenik et al.
FREE RADICAL RESEARCH (2001)
Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons
S Erhardt et al.
AMINO ACIDS (2001)
3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote α-crystallin cross-linking by metal ion reduction
LE Goldstein et al.
BIOCHEMISTRY (2000)
Early kynurenergic impairment in Huntington's Disease and in a transgenic animal model
P Guidetti et al.
NEUROSCIENCE LETTERS (2000)
Heme: A regulator of rat hepatic tryptophan 2,3-dioxygenase?
SY Ren et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
Comparative effects of oxygen on indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase of the kynurenine pathway
YH Dang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2000)
Selective metabolism of kynurenine in the spleen in the absence of indoleamine 2,3-dioxygenase induction
MG Espey et al.
IMMUNOLOGY LETTERS (2000)
Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis
GJ Guillemin et al.
REDOX REPORT (2000)
Anticonvulsant effects of the 3-hydroxyanthranilic acid dioxygenase inhibitor NCR-631
J Luthman
AMINO ACIDS (2000)
Share Paper
